Abou-Shoer M .2010 .A simple calorimetric method. American Journal of Analytical Chemistry, 1 : 12012.
Ahrén B,Foley J .2008 .The islet enhancer vildagliptin: mechanisms of improved glucose metabolism. International Journal of Clinical Practice, 62(159) : 8-14.
Alemu F .2015 .Prevalence of diabetes mellitus disease and its association with level of education among adult patients attending at Dilla Referral Hospital, Ethiopia. Journal of Diabetes and Metabolism, 6 : 521.
Aulbach AD,Amuzie CJ .2017 .A comprehensive guide to toxicology in non-clinical drug development. 2nd Edition, : 447-471.
Azizi R,Goodarzi Z,MT Z .2014 .Effect of Biochanin-A on serum visfatin levels in STZ-induced diabetic rats. Iran Red Crescent Medical Journal, 16(9) : 1-7.
Cernea S and Raz I .2011 .Therapy in the early stage: incretins. Diabetes Care. 34 Suppl, : S264-S271.
Chamberlain JJ,Herman WH,Leal S,Rhinehart AS .2017 .Pharmacological therapy for type 2 diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes. Annals of Internal Medicine, 166(8) : .
Cheatham WW .2010 .Peroxisome proliferator-activated receptor translational research and clinical experience. American Journal of Clinical Nutrition, 91 : 262S-e266S.
Danaei G,Finucane MM,Lu Y,Singh GM,Cowan MJ,Paciorek CJ,Lin JK,Farzadfar F,Khang Y,Stevens GA,Rao M,Ali MK,Riley LM,Robinson CA,Ezatti M .2011 .global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet, 378 : 31-40.
Godinho R,Mega C,Teixeira de Lemos E,Carvalho E,Teixeira F,Fernandes R,Reis F .2015 .. , : .